18F-MK-6240

DRUG5 trials

Sponsors

Yaakov Stern, Patrick Lao, Adam Brickman, José A. Luchsinger, NYU Langone Health

Conditions

AgingAlzheimer DiseaseMild Cognitive Impairment

Early Phase 1

Brain Imaging in the Diabetes Prevention Program Outcomes Study

TerminatedNCT03757910

José A. LuchsingerAlzheimer Disease

Start: 2019-10-01End: 2023-01-31Updated: 2024-03-04

Phase 1

Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults

CompletedNCT03706261

Adam BrickmanAlzheimer Disease

Start: 2019-03-22End: 2023-07-14Updated: 2025-08-01

Phase 2

Imaging Tau in Alzheimer's Disease and Normal Aging

CompletedNCT03373604

Patrick LaoAlzheimer Disease

Start: 2017-12-11End: 2022-05-11Updated: 2025-05-08

Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)

Active, not recruitingNCT04784416

NYU Langone HealthAlzheimer Disease, Mild Cognitive Impairment

Start: 2021-04-27End: 2026-01-31Updated: 2025-12-09

Unknown Phase

Tau PET in Imaging and Cognition: Healthy Adults From 55-90

RecruitingNCT03372317

Yaakov SternAging, Mild Cognitive Impairment

Start: 2018-06-01End: 2027-12-01Target: 105Updated: 2026-02-11

Related Papers

Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer’s Disease

Journal of Alzheimer s Disease2021-02-2051 citations